Bioinformatics becomes a bottleneck in biopharma R&D when next-generation sequencing (NGS) data generation exceeds internal analytical capacity. Without specialized expertise, complex genomic variants may be missed, delaying insight and increasing development risk. In biopharma research, sequencing capacity is rarely the constraint. Analytical capacity often is. Teams can generate high-quality NGS data at scale — yet The post When Bioinformatics Is the Bottleneck: Enabling Complex Viral Analysis